1887
Rapid communications Open Access
Like 0

Abstract

Successful treatment of gonorrhoea is the mainstay of public health control. Cefixime and ceftriaxone, highly active third generation cephalosporins, are today the recommended first-line agents in most countries and azithromycin is a second-line agent. However, there is increasing evidence of decreasing susceptibility and emergence of therapeutic failures. In this report two cases of clinical failure to cefixime are described, one of which additionally shows failure to azithromycin and selection of a less susceptible strain during treatment.

Loading

Article metrics loading...

/content/10.2807/ese.16.14.19833-en
2011-04-07
2017-12-18
http://instance.metastore.ingenta.com/content/10.2807/ese.16.14.19833-en
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/16/14/art19833-en.htm?itemId=/content/10.2807/ese.16.14.19833-en&mimeType=html&fmt=ahah
Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error